PQ Bypass

**PQ Bypass** is a Silicon Valley-based medical device company aiming to enhance the treatment of long-segment peripheral artery disease through minimally-invasive endovascular solutions. Founded in **2009**, it was previously a Company-In-Residence at the Fogarty Institute for Innovation. The leadership team comprises professionals with extensive experience in the medical device sector, having held senior roles at renowned companies such as **Medtronic**, **Abbott**, **Johnson & Johnson**, **Covidien**, and **Stryker**, while also contributing to the development of medical devices for venture-backed startups like **Evalve**, **AccessClosure**, **Altura**, and **DVI**. The company recently secured a significant **$60.00M** Private Equity Round investment on **08 January 2019**. This funding round saw participation from notable investors including **Medical Technology Venture Partners**, **Seroba Life Sciences**, and **Deerfield Capital Management**. PQ Bypass' dedication to innovation and its leadership's deep industry expertise position the company as a pivotal player in the minimally-invasive treatments realm within the **Health Care** and **Medical Devices** industries. With its strong investor backing and experienced leadership, PQ Bypass is primed to make a significant impact in the medical device landscape.